About Hôpital Pellegrin-Enfants
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Allergan
2
Institut de Recherches Internationales Servier
2
Amzell
1
Ascendis Pharma A/S
1
Baxalta now part of Shire
1
Centre Oscar Lambret
1
ERYtech Pharma
1
Eisai Inc.
1
Hospices Civils de Lyon
1
Janssen Research & Development, LLC
1
Michaël Hofer
1
Clinical Trials at Hôpital Pellegrin-Enfants
During the past decade, Hôpital Pellegrin-Enfants conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 8 clinical trials were completed, i.e. on
average, 80% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 5 clinical trials were completed. i.e. 500%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study to Demonstrate the Efficacy and Safety of Propranolol Oral Solution in Infants With Proliferating Infantile Hemangiomas Requiring Systemic Therapy
2010-01-01
2013-11-01
Completed
512
Clinical Trial of Rapamycin and Irinotecan in Pediatric Patients With Refractory Solid Tumors
2011-04-22
2013-02-20
Completed
42
Vincristine and Irinotecan With or Without Temozolomide in Children and Adults With Refractory/Relapsed Rhabdomyosarcoma
2012-01-01
2019-05-01
Completed
120
A Study of the Efficacy and Safety of Pregabalin as Add-On Therapy for Partial Onset Seizures in Children Ages 4-16 Years
2011-09-27
2016-08-10
Completed
295
GRASPA (Erythrocytes Encapsulating L-asparaginase) in Patients With Relapse of Acute Lymphoblastic Leukemia
2009-12-01
2016-10-01
Completed
85
Study of OnabotulinumtoxinA (BOTOX®) for Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Pediatric Patients
2013-07-02
2018-10-11
Completed
114
A Long-Term Extension Study of OnabotulinumtoxinA (BOTOX®) for Urinary Incontinence Due to Neurogenic Detrusor Overactivity
2014-01-11
2019-10-03
Completed
95
Safety, PK/PD (Pharmacokinetics/Pharmacodynamics) and Efficacy of ACP-001 Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD)
2013-07-01
2015-09-01
Completed
53
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Hôpital Pellegrin-Enfants" #1 sponsor was "Allergan" with 2 trials, followed by "Institut de Recherches Internationales Servier" with 2 trials
sponsored, "Amzell" with 1 trials sponsored, "Ascendis Pharma A/S" with 1 trials sponsored and "Baxalta now part of Shire"
with 1 trials sponsored. Other sponsors include 8 different institutions and
companies that sponsored additional 18 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Hôpital Pellegrin-Enfants"
#1 collaborator was "ADIR, a Servier Group company" with 2 trials as a collaborator, "Baxalta Innovations GmbH, now part of Shire" with 1 trials as a collaborator, "Bicetre Hospital" with 1 trials as a collaborator, "Gustave Roussy, Cancer Campus, Grand Paris" with 1 trials as a collaborator and "Hospices Civils de Lyon" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were
collaborators in the rest 13 trials.
Clinical Trials Conditions at Hôpital Pellegrin-Enfants
According to Clinical.Site data, the most researched conditions in "Hôpital Pellegrin-Enfants" are
"Autism Spectrum Disorder (ASD)" (2 trials), "Urinary Incontinence" (2 trials), "ADHD Inattention or Mixed Type" (1 trials), "Acute Lymphoblastic Leukemia, in Relapse" (1 trials) and "Arthritis, Juvenile Rheumatoid" (1 trials). Many other conditions were trialed in "Hôpital Pellegrin-Enfants" in a lesser frequency.
Clinical Trials Intervention Types at Hôpital Pellegrin-Enfants
Most popular intervention types in "Hôpital Pellegrin-Enfants" are "Drug" (14 trials), "Biological" (4 trials), "Device" (1 trials), "Dietary Supplement" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "OnabotulinumtoxinA" (2 trials), "PLACEBO" (2 trials), "Placebo" (2 trials), "6-mercaptopurine" (1 trials) and "ACP-001" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Hôpital Pellegrin-Enfants
The vast majority of trials in "Hôpital Pellegrin-Enfants" are
19 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Hôpital Pellegrin-Enfants
Currently, there are NaN active trials in "Hôpital Pellegrin-Enfants".
undefined are not yet recruiting,
1 are recruiting,
undefined are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 15 completed trials in Hôpital Pellegrin-Enfants,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Hôpital Pellegrin-Enfants, 1 "Phase 1"
clinical trials were conducted, 6 "Phase 2" clinical
trials and 11 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 1 trials that are defined as “Not Applicable".